Page 26 - Covid 26 July 2021

C-CAMP is augmenting Karnataka’s healthcare infrastructure for
COVID-19 with support from Mercedes Benz R&D India
C-CAMP has received CSR funding from Mercedes Benz Research & Development India (MBRDI) towards deploying about 110 oxygen concentrators from Germany in public healthcare centres across Karnataka.
The effort that has been facilitated by Nayonika Eye Care Charitable Trust, the German Consulate General, Bangalore and Indian Embassy in Germany is one of the many national and international CSR fundraising initiatives being coordinated by C-CAMP to aid India’s COVID-19 response with life-saving technologies and innovations.
Dr Taslimarif Saiyed, then C-CAMP CEO & Director said, “Oxygen concentrators have the potential to address the critical gap in oxygen supply that we are witnessing across India. Lives can be saved with this technology. C-CAMP is happy to contribute to Karnataka’s ongoing combat by bringing this much needed resource to the State. We are planning on collaborating with the Government of Karnataka on deployment in public healthcare centres including makeshift hospitals and COVID care facilities, which especially lack infrastructure for cryogenic oxygen.”
Given the prohibitive cost and logistics associated with liquid oxygen tankers and the dearth of pressurised medical oxygen, oxygen concentrators have emerged as a less expensive, more convenient and foolproof alternative. Oxygen concentrators concentrate the oxygen from ambient air by selectively removing nitrogen to supply an oxygen-enriched gas stream using pressure swing adsorption (PSA) technology. The consignment of 110 concentrators imported by C-CAMP have been manufactured by Phillips, are lightweight, easy-to-use and low maintenance.
Speaking on the importance of such multi-partner PPP collaborations in rapid mobilisation during this time of emergency, Dr Taslim remarked that “The C-CAMP-MBRDI partnership was turned around in unprecedented urgency and definitely shows the way for greater ecosystem participation in order to bring forward more helping hands from India and abroad in this hour of need.”
C-CAMP is no stranger to multi-partner coalitions for emergency response to the pandemic. As India’s premier bio innovation hub, it has implemented, anchored and expressly mobilised three of India’s most crucial multi-partner innovation programmes, C-CIDA, N-BRIC and InDx to give teeth to the public healthcare system in the form of diagnostics, therapeutics, vaccine delivery, etc.
Website link:
https://www.ccamp.res.in/c-camp-augmenting-karnataka%E2%80%99s- healthcare-infrastructure-covid-19-support-mercedes-benz-rd-india
***
VOL. IV ISSUE 7
VIGYAN PRASAR 22
COVID-19 SCIENCE & TECHNOLOGY EFFORTS IN INDIA